Close

Prof John Cairns

Professor of Health Economics

United Kingdom

I studied economics at the University of Aberdeen and at the University of York. My first post was as a research fellow in health economics at the University of York. I then returned to Aberdeen first as a lecturer in economics and then as a senior research fellow, reader and professor in the Health Economics Research Unit (HERU). I was director of HERU 1993-2000. I have been a professor of health economics in the faculty of Public Health & Policy at LSHTM since 2004.

I have been a member of the NICE diagnostics advisory committee since 2020. I was previously a member of the NICE technology appraisal committee 2003-2020 and the Scottish Medicines Consortium 2003-2009. I am currently a member of the NIHR advanced fellowships selection committee and have previously been a member of the NIHR HTA commissioning board, policy research unit panel, research support service – independent selection committee and research methods panel.

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Centres

Global Health Economics Centre

Teaching

My main teaching activities in 2022-23 were as a lecturer on MSc Public Health modules Introduction to Health Economics, Economic Evaluation and Environmental Health Policy, and as a tutor on the distance learning module Economic Evaluation. I also taught on the Economic Analysis for Health Policy, Health Services and the DrPH Evidence-based Public Health Policy modules.

Research

My two main research interests concern the use of economic evaluation to inform healthcare decision-making and the measurement of health preferences and outcomes. NICE health technology appraisals are a rich source of examples of the use of economics to inform decision-making. Recent studies I have undertaken with others include: the use of real-world data in appraisals on oncology medicines, the operation of the Cancer Drugs Fund and the use by NICE of decision modifiers. Recent preference studies on which I have collaborated include: a comparison of blood donors’ revealed and stated preferences, a contingent valuation study conducted with children and their parents, and using best-worst scaling to elicit head and neck cancer patients’ preferences.

I have participated in a wide range of economic evaluations, including: smoking cessation, tranexamic acid in bleeding trauma patients, mammographic screening, early infant HIV diagnosis and treatment, HCV treatment, surveillance after treatment for head and neck cancer, organisation of blood donation, post-abortion family planning, screening for persistent hepatitis E, antenatal anti-D prophylaxis, imaging strategy for acute stroke, treatment of childhood empyema, screening for open-angle glaucoma, surgical treatment of uterine fibroids, reclaiming hazardous waste sites, extracorporeal membrane oxygenation, and 20 MPH zones.
Research Area
Health economics
Health technology assessment
Economic evaluation
Economics (social science)
Disease and Health Conditions
Cancer
Eye health
Country
United Kingdom

Selected Publications

The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
MEREGAGLIA, M; CAIRNS, J; Licitra, L; Bossi, P;
2018
European journal of cancer (Oxford, England
In search of a common currency: A comparison of seven EQ-5D-5L value sets.
Olsen, JA; Lamu, AN; CAIRNS, J;
2017
Health economics
Estimating Health-State Utility Values in Kidney Transplant Recipients and Waiting-List Patients Using the EQ-5D-5L.
LI, B; CAIRNS, JA; Draper, H; Dudley, C; Forsythe, JL; Johnson, RJ; Metcalfe, W; Oniscu, GC; Ravanan, R; Robb, ML; Roderick, P; Tomson, CR; Watson, CJ E; Bradley, JA;
2017
Value in health
External Validity of Contingent Valuation: Comparing Hypothetical and Actual Payments.
Ryan, M; Mentzakis, E; Jareinpituk, S; CAIRNS, J;
2016
Health economics
Exploring patient and clinician perspectives on the benefits and risks of emerging therapies for the treatment of haemophilia: a qualitative study
Spoors, J; Payne, K; Wright, S; Horsley, W; BELL, S; CAIRNS, J;
2024
The Journal of Haemophilia Practice
Using automated text classification to explore uncertainty in NICE appraisals for drugs for rare diseases.
WIEDMANN, L; Blumenau, J; CARROLL, O; CAIRNS, J;
2024
International journal of technology assessment in health care
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods Manual.
ANGELIS, A; HARKER, M; CAIRNS, J; Seo, MK; LEGOOD, R; Miners, A; WISEMAN, V; Chalkidou, K; GRIEVE, R; BRIGGS, A;
2023
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
See more information